Successful Conclusion｜LBE Pharma Unveils a New Chapter in Precision Drug Delivery and CDMO Excellence

Frankfurt, Germany – October 30, 2025

The three-day CPHI Europe 2025 wrapped up successfully at Messe Frankfurt, marking another milestone for LBE Pharma. Highlighting our dual core strengths in Combination Drug–Device Solutions and Complex Formulation CDMO Platforms, we made a powerful showcase at Booth 9.1A89. Our team engaged in productive dialogues with hundreds of industry experts and potential partners, sparking significant interest and paving the way for promising collaborations.

Highlights: Showcase Spotlight: Where Innovation Stole the Show

Epinephrine Autoinjector Draws Broad Attention
Our innovative epinephrine autoinjector solution attracted widespread interest for its precision dosing performance, user-friendly design, flexible customization, and scalable manufacturing capability. Dozens of pharmaceutical companies expressed keen interest in our pre-filled auto-injector and customized design services, with several initiating discussions on concrete partnership opportunities.

Dual-Chamber Filling and Drug Delivery Platform Gains Industry Recognition
Addressing technical challenges in complex formulations, our dual-chamber cartridge and prefilled syringe technologies stood out as another key highlight. Featuring excellent container closure integrity, accurate dose control, and easy clinical usability, these solutions provide reliable support for “mix-before-use,” stable storage, and complex formulation needs, earning high praise from multiple pharmaceutical technology firms.

CDMO Capabilities Inspire Client Confidence
Our comprehensive CDMO service platform also captured significant attention. LBE Pharma showcased its expertise in complex formulation development, multi-format aseptic filling (vials, cartridges, prefilled syringes, etc.), robust quality management systems, and global regulatory support. Many potential partners held detailed discussions on process development, tech transfer, commercial production, and regulatory submissions, laying a strong foundation for future collaborations.

Moving Forward: Deepening Technology, Empowering Globally

CPHI Europe 2025 was more than a showcase — it was a bridge connecting LBE Pharma with global pharmaceutical partners to co-create the future. We gained valuable market insights, client feedback, and strategic relationships that will drive our next stage of growth.

Looking ahead, LBE Pharma will continue to invest in R&D, optimize precision drug delivery and complex formulation platforms, and expand our CDMO service breadth and depth — to better meet the evolving needs of clients worldwide.

See You in the Middle East!

We’re already gearing up for CPHI Middle East 2026, taking place in Riyadh, Saudi Arabia this coming May (Booth H2.B10). Join us as we unveil new innovations and enhanced service solutions — and continue our journey of collaboration and global impact.

#LBEPharma #CPHIEurope2025 #CDMO #DrugDelivery #PharmaInnovation #CombinationProduct #ComplexFormulations #GlobalPartnerships #PharmaIndustry #Riyadh2026